Share chart BioAtla, Inc.
Extended chart
Simple chart
About BioAtla, Inc.
BioAtla, Inc., биофармацевтическая компания, разрабатывает специфические и селективные терапевтические препараты на основе антител для лечения различных видов рака. Его ведущим кандидатом в продукт является BA3011, условно активный биологический (CAB) конъюгат антитело-лекарственное средство (ADC) для лечения опухолей саркомы мягких тканей и костей, немелкоклеточного рака легкого (NSCLC) и других типов опухолей. more details| IPO date | 2020-12-16 |
|---|---|
| ISIN | US09077B1044 |
| Industry | Biotechnology |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Див.доход ао | 0 |
| Сайт | https://www.bioatla.com |
| Цена ао | 0.4184 |
| Change price per day: | -3.19% (0.4322) |
|---|---|
| Change price per week: | -11.97% (0.4753) |
| Change price per month: | +38.22% (0.3027) |
| Change price per 3 month: | +5.15% (0.3979) |
| Change price per half year: | -78.97% (1.99) |
| Change price per year: | -83.97% (2.61) |
| Change price per 3 year: | -82.85% (2.44) |
| Change price per year to date: | -29.08% (0.59) |
|
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
|||||||||||||||||||||||||||||||||||||
| Institutions | Volume | Share, % |
|---|---|---|
| Soleus Capital Management, L.P. | 4065197 | 8.45 |
| Blackrock Inc. | 2884014 | 6 |
| Tang Capital Management, LLC | 2524076 | 5.25 |
| Vanguard Group Inc | 2081370 | 4.33 |
| Morgan Stanley | 1913115 | 3.98 |
| Cormorant Asset Management, LP | 1181115 | 2.46 |
| Deutsche Bank Aktiengesellschaft | 1125203 | 2.34 |
| Renaissance Technologies, LLC | 987500 | 2.05 |
| Geode Capital Management, LLC | 904080 | 1.88 |
| State Street Corporation | 724369 | 1.51 |
| Head | Job title | Payment | Year of birth |
|---|---|---|---|
| Mr. Richard A. Waldron | Senior VP & CFO | 617.62k | 1954 (71 year) |
| Ms. Susie Melody | Senior Vice President of Human Resources | N/A | |
| Dr. Cathy Chang Ph.D. | Senior Vice President of Research & Development | N/A | |
| Dr. Jay M. Short Ph.D. | Co-Founder, CEO & Chairman | 1.06M | 1958 (67 years) |
| Dr. Eric L. Sievers M.D. | Chief Medical Officer | 608.18k | 1964 (61 year) |
| Ms. Monica Sullivan | Senior Vice President of Intellectual Property & Contracts | N/A | |
| Dr. Gerhard Frey Ph.D. | Senior Vice President of Technology Development | N/A | |
| Mr. Christian J. Vasquez | Chief Accounting Officer, Controller and Corporate Secretary | 408.75k | 1976 (49 years) |
| Ms. Sheri Lydick | Chief Commercial Officer | N/A | |
| Dr. Bin Zhang M.D., M.Sc. | Senior Vice President of Clinical Development |
Address: United States, San Diego, 11085 Torreyana Road - open in Google maps, open in Yandex maps
Website: https://www.bioatla.com
Website: https://www.bioatla.com
